参考文献/References:
[1] 陈 朴,张立营,彭宇生,等.850例女性人乳头瘤病毒筛查基因型结果回顾性分析[J].检验医学与临床,2011,8(23):2858-2859,2861.
Chen P,Zhang LY,Peng YS,et al.Retrospective analysis of genotypes of human papillomavirus infection in 850 cases of women suspected HPV infection[J].Lab Med Clin,2011,8(23):2858-2859,2861.
[2] 张桂前,苏 敏,孙 鹥.1 132例妇科门诊病人HPV分型检测的结果分析[J].现代预防医学,2013,40(3):458-459,466.
Zhang GQ,Su M,Sun Y.HPV Sub-type analysis of 1 132 outpatients[J].Modern Prevention Medicine,2013,40(3):458-459,466.
[3] 刘 邺,成 建.南京地区妇女宫颈人乳头瘤病毒感染和亚型分布情况[J].南京医科大学学报(自然科学版),2013,33(2):206-209.
Liu Y,Cheng J.Prevalence and genotype distribution of cervical human papillomavirus infection amongwomen in Nanjing[J].Acta University MedicalNanjing(Natural Science),2013,33(2):206-209.
[4] 何君梅,尹格平.21种HPV亚型检测在宫颈病变诊断及预测中的价值[J].山东医学,2010,50(15):35-36.
He JM,Yin GP.Value of the detection of 21 Sub-type of HPV in thediagnosis and prediction of cervical lesions[J].Shandong Medicine,2010,50(15):35-36.
[5] 陈光辉,隋 洪,何淑明,等.611例宫颈拭子HPV亚型检测结果分析[J].广东医学院学报,2011,29(5):534-536.
Chen GH,Sui H,He SM,et al.Analysis of 611 Cervix Swab Cases HPV Sub-type Test[J].Journal of Guangdong Medical College,2011,29(5):534-536.
[6] 姜 丹,叶劲东,张晓平,等.深圳市万名流动妇女HPV感染现状分析[J].中国公共卫生管理,2012,28(6)796-797.
Jiang D,Ye JD,Zhang XP,et al.Analysis of infection of HPV among 10 000 female migrant population in Shenzhen[J].Chinese Journal of Public Health Management,2012,28(6):796-797.
[7] Sun ZR,Ji YH,Zhou WQ et al.Characteristics of HPV prevalence among women in Liaoning province,China[J].Int J Gynaecol Obstet,2010,109(2):105-109.
[8] 杨小艺,李 娜,王海宁.1 083例妇女HPV感染状况分析[J].陕西医学杂志,2012,41(6):739-741.
Yang XY,Li N,Wang HN.Analysis of HPV infection cases of 1 083 women[J].Shaanxi Medical Journal,2012,41(6):739-741.
[9] 刘 曌,白慧丽,陶 林,等.新疆地区妇女宫颈病变组织中HPV感染与分型研究[J].中华实用诊断与治疗杂志,2013,27(3):243-244.
Liu Z,Bai HL,Tao L,et al.HPV infection and typing in women withcervical lesions in Xinjiang[J].Journal of Chinese Practical Diagnosis and Therapy,2013,27(3):243-244.
[10] 刘朝圣,陈 新,连 石.北京地区妇女宫颈人乳头瘤病毒感染及亚型分布情况分析[J].中国艾滋病性病,2012,18(9):604-606.
Liu CS,Chen X,Liao S.Human papillomavirus infection in married women and its subtype distribution in Beijing[J].Chinese Journal of AIDS&STD,2012,18(9):604-606.
[11] 潘 莉,潘 伟.妇科门诊患者HPV分型检测及结果分析[J].医学信息,2010,23(9):3372-3373.
Pan L,Pan W.HPV Sub-type analysis of gynecological outpatients HPV test[J].Medical Information,2010,23(9):3372-3373.
[12] 张春蕾,华正宇,袁小林,等.大连地区454例健康体检女性人乳头瘤病毒感染调查[J].中国妇幼保健,2013,28(7):1134-1137.
Zhang CL,Hua ZY,Yuan XL,et al.Investigation on 454 women with HPV infection found by health physical examination in Dalian[J].Maternal&Child HealthCare of China,2013,28(7):1134-1137.
[13] 李志锋,谢礼丽,张 颂,等.苏州地区宫颈病患者HPV感染亚型分析[J].江苏预防医学,2011,22(5):7-9.
Li ZF,Xie LL,Zhang S,et al.Sub-type specific distribution of HPV cases with cervical diseases in Suzhou[J].Jiangsu Journal Prevention Medicine,2011,22(5):7-9.
[14] Wang S,Wei H,Wang N,et al.The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China[J].BMC Cancer,2012,12(1):160.
[15] 蒋燕成,张志珊,郑红云.中国泉州、武汉两个地区女性宫颈HPV感染的差异性及其基因型分布[J].现代检验医学杂志,2014,29(5):28-30,33.
Jiang YC,Zhang ZS,Zheng HY.Comparative research on infection rates and gene spectrum of cervical cells in women infected with HPV in Quanzhou and Wuhanregions of China[J].Journal of Modern Laboratory Medicine,2014,29(5):28-30,33.
[16] 王 妍,黄钦贤,林章礼,等.汕头地区女性HPV的感染状况回顾[J].现代检验医学杂志,2015,30(4):122-124.
Wang Y,Huang QX,Lin ZL,et al.Review of HPV infection status of the women in Shantou region[J].Journal of Modern Laboratory Medicine,2015,30(4):122-124.
[17] 高 琨,李 力,杨 梅.广西南宁地区妇女子宫颈HPV感染型别的分析[J].中国癌症防治杂志,2011,3(3):203-206.
Gao K,Li L,Yang M.Subtype analysis of human papillomavirus among the cervix-infected women in Nanningarea of Guangxi[J].China Journal of Oncology Prevention and Treatment,2011,3(3)203-206.
相似文献/References:
[1]孔倩倩a,唐振华,相芬芬a,等.抗HPV18 E6多肽单克隆抗体的制备及鉴定[J].现代检验医学杂志,2016,31(03):30.[doi:10.3969/j.issn.1671-7414.2016.03.009]
KONG Qian-qiana,TANG Zhen-hua,XIANG Fen-fena,et al.Preparation and Identification of A Peptide Monoclonal Antibody
Against Human Papillomavirus 18E6[J].Journal of Modern Laboratory Medicine,2016,31(06):30.[doi:10.3969/j.issn.1671-7414.2016.03.009]
[2]王 冰,朱月蓉,何玉杰,等.血清结合珠蛋白在宫颈癌诊断中的应用研究[J].现代检验医学杂志,2017,32(01):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
WANG Bing,ZHU Yue-rong,HE Yu-jie,et al.Application of Haptoglobin in Cervical Cancer Diagnosis[J].Journal of Modern Laboratory Medicine,2017,32(06):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
[3]林金端a,刘红伟a,张欣宁b,等.Mybl2在不同病变程度宫颈组织中的表达[J].现代检验医学杂志,2017,32(02):141.[doi:10.3969/j.issn.1671-7414.2017.02.039]
LIN Jin-duana,LIU Hong-weia,ZHANG Xin-ningb,et al.Expression Level and Clinical Significance of Mybl2 in Cervical Tissues[J].Journal of Modern Laboratory Medicine,2017,32(06):141.[doi:10.3969/j.issn.1671-7414.2017.02.039]
[4]韩 伟a,刘文康b,翟卫斌c,等.西安地区男性尿道感染人乳头瘤病毒基因亚型分析[J].现代检验医学杂志,2017,32(03):52.[doi:10.3969/j.issn.1671-7414.2017.03.014]
HAN Weia,LIU Wen-kangb,ZHAI Wei-binc,et al.Detection of Human Papillomavirus Subtypes
in Male Urethra in Xi’an Area[J].Journal of Modern Laboratory Medicine,2017,32(06):52.[doi:10.3969/j.issn.1671-7414.2017.03.014]
[5]原 荣a,李 军a,南 星a,等.陕西省宝鸡和咸阳两地妇女HPV感染现状和类型分析[J].现代检验医学杂志,2017,32(06):145.[doi:10.3969/j.issn.1671-7414.2017.06.001]
YUAN Ronga,LI Juna,NAN Xinga,et al.HPV Prevalence and Subtypes Analysis of Women in Baoji
and Xianyang Area of Shaanxi Province[J].Journal of Modern Laboratory Medicine,2017,32(06):145.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[6]冯 磊,常春红,管晓卿,等.宫颈癌患者血浆miRNA-10b的表达及其临床意义[J].现代检验医学杂志,2018,33(01):52.[doi:10.3969/j.issn.1671-7414.2018.01.001]
FENG Lei,CHANG Chun-hong,GUAN Xiao-qing,et al.Expression of Plasma miRNA-10b
in Patients with Cervical Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2018,33(06):52.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[7]林丽慧,唐 梅,于春玲,等.HPV阳性宫颈癌和CIN患者血浆miR-150,SCCA及CA125的表达及临床意义[J].现代检验医学杂志,2018,33(02):62.[doi:10.3969/j.issn.1671-7414.2018.02.001]
LIN Li-hui,TANG Mei,YU Chun-ling,et al.Expression and Clinical Significance of Plasma miR-150,SCCA
and CA125 in Patients with HPV Positive Cervical Cancer and CIN[J].Journal of Modern Laboratory Medicine,2018,33(06):62.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[8]刘 娅,贺 巧,佘佳琪.宫颈癌患者治疗前血浆凝血四项指标与生存率的相关性研究[J].现代检验医学杂志,2019,34(03):137.[doi:10.3969/j.issn.1671-7414.2019.03.035]
LIU Ya,HE Qiao,SHE Jia-qi.Correlation between the Four Indicators of Coagulation andPrognosis in Patients with Cervical Carcinoma before Treatment[J].Journal of Modern Laboratory Medicine,2019,34(06):137.[doi:10.3969/j.issn.1671-7414.2019.03.035]
[9]沈华,盛晓鹃.HPV 阳性宫颈癌组织中IGF2BP2 和RPRD1B 的表达水平及临床价值研究[J].现代检验医学杂志,2023,38(05):121.[doi:10.3969/j.issn.1671-7414.2023.05.023]
SHEN Hua,SHENG Xiaojuan.Expression and Clinical Value of IGF2BP2 and RPRD1B in HPV Positive Cervical Cancer Tissues[J].Journal of Modern Laboratory Medicine,2023,38(06):121.[doi:10.3969/j.issn.1671-7414.2023.05.023]
[10]徐 幸,王国飞,杨依绡,等.2020~2022年度上海及其他省市临床实验室HPV6型与HPV11型核酸检测室间质量评价结果分析[J].现代检验医学杂志,2024,39(01):179.[doi:10.3969/j.issn.1671-7414.2024.01.034]
XU Xing,WANG Guofei,YANG Yixiao,et al.Analysis of External Quality Assessment Results for HPV6 and HPV11 Nucleic Acid Testing in Clinical Laboratories of Shanghai and Other Provinces and Cities from 2020 to 2022[J].Journal of Modern Laboratory Medicine,2024,39(06):179.[doi:10.3969/j.issn.1671-7414.2024.01.034]
[11]王 妍,黄钦贤,林章礼,等.汕头地区女性HPV的感染状况回顾[J].现代检验医学杂志,2015,30(04):122.[doi:10.3969/j.issn.1671-7414.2015.04.036]
WANG Yan,HUANG Qin-xian,LIN Zhang-li,et al.Review of HPV Infection Status of the Women in Shantou Region[J].Journal of Modern Laboratory Medicine,2015,30(06):122.[doi:10.3969/j.issn.1671-7414.2015.04.036]
[12]原 荣,李 军,南 星,等.陕西省安康和延安两地区妇女HPV感染及型别分布对比研究[J].现代检验医学杂志,2017,32(02):64.[doi:10.3969/j.issn.1671-7414.2017.02.017]
YUAN Rong,LI Jun,NAN Xing,et al.Comparative Study on HPV Infection and Hypotype Distribution
between Ankang and Yan'an Area of Shaanxi Province[J].Journal of Modern Laboratory Medicine,2017,32(06):64.[doi:10.3969/j.issn.1671-7414.2017.02.017]